Truist Financial Corp Vericel Corp Transaction History

Truist Financial Corp

$71.8 Billion
Q3 2025

A detailed history of Truist Financial Corp transactions in Vericel Corp stock. As of the latest transaction made, Truist Financial Corp holds 61,798 shares of VCEL stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,798

Previous 61,280 0.85%

Holding current value

$2.46 Million

Previous $2.61 Million 25.43%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	BUY	$29.84 - $41.74 $15,457 - $21,621	518 Added 0.85%	61,798 $1.94 Million
Q2 2025 Jul 18, 2025	BUY	$37.92 - $45.7 $22,714 - $27,374	599 Added 0.99%	61,280 $2.61 Million
Q1 2025 Apr 29, 2025	BUY	$44.5 - $61.8 $394,003 - $547,177	8,854 Added 17.08%	60,681 $2.71 Million
Q4 2024 Jan 31, 2025	BUY	$40.05 - $59.11 $28,515 - $42,086	712 Added 1.39%	51,827 $2.85 Million
Q3 2024 Nov 13, 2024	BUY	$42.25 - $53.56 $65,783 - $83,392	1,557 Added 3.14%	51,115 $2.16 Million

Q2 2024 Aug 20, 2024	SELL	$41.71 - $52.9 $367,965 - $466,683	-8,822 Reduced 15.11%	49,558 $2.27 Million
Q1 2024 May 10, 2024	BUY	$32.52 - $52.33 $35,576 - $57,249	1,094 Added 1.91%	58,380 $3.04 Million
Q4 2023 Feb 02, 2024	BUY	$30.85 - $37.09 $70,276 - $84,491	2,278 Added 4.14%	57,286 $2.04 Million
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $34,922 - $43,253	1,102 Added 2.04%	55,008 $1.84 Million
Q2 2023 Aug 01, 2023	SELL	$29.0 - $38.37 $3,596 - $4,757	-124 Reduced 0.23%	53,906 $2.03 Million
Q1 2023 May 05, 2023	SELL	$23.85 - $31.34 $76,987 - $101,165	-3,228 Reduced 5.64%	54,030 $1.58 Million
Q4 2022 Feb 17, 2023	SELL	$17.65 - $27.37 $123,461 - $191,453	-6,995 Reduced 10.89%	57,258 $1.51 Million
Q3 2022 Oct 26, 2022	BUY	$22.62 - $32.54 $232,149 - $333,958	10,263 Added 19.01%	64,253 $1.49 Million
Q2 2022 Jul 22, 2022	SELL	$22.88 - $39.45 $231,911 - $399,865	-10,136 Reduced 15.81%	53,990 $1.36 Million
Q1 2022 Apr 22, 2022	BUY	$31.69 - $43.29 $1.74 Million - $2.37 Million	54,779 Added 586.06%	64,126 $2.45 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $43,718 - $65,329	-1,242 Reduced 11.73%	9,347 $367,000
Q3 2021 Nov 05, 2021	BUY	$46.35 - $59.75 $24,982 - $32,205	539 Added 5.36%	10,589 $517,000
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $117,008 - $168,100	2,479 Added 32.74%	10,050 $527,000
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $234,171 - $450,323	7,571 New	7,571 $420,000

Others Institutions Holding VCEL

# of Institutions

273

Shares Held

52.7M

Call Options Held

36.6K

Put Options Held

9.1K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.88B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Vericel Corp Transaction History